pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,785 catalysts · 4,779 phase readout · 2,339 8k filing · 286 earnings · 271 pdufa · 166 phase 2 completion · 71 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: grant×type: filing×clear all
type
  • phase readout4,779
  • 8k filing2,339
  • earnings286
  • pdufa271
  • phase 2 completion166
  • phase 1 completion71
phase 2 initiation
54
  • phase 1 initiation39
  • phase 1 2 completion33
  • phase 0 trial completion23
  • therapy area
    • Ophthalmology5

    Date TBD

    50
    ›COMPLETEDphase readoutNCT02007499: Pre-arrival Instructions Effect on Bystander Cardiopulmonary Resuscitation (CPR).

    Sponsor: Medical College of Wisconsin. Phase: . Conditions: Heart Arrest, Cardiac Arrest, Cardiopulmonary Arrest, Out of Hospital Cardiac Arrest, Sudden Cardiac Death

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT01545999: Paired Associative Stimulation in the Dorsolateral Prefrontal Cortex in Patients With Schizophrenia

    Sponsor: Centre for Addiction and Mental Health. Phase: NA. Conditions: Schizophrenia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07105098: NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

    Sponsor: Neurocrine Biosciences. Phase: PHASE3. Conditions: Schizophrenia

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07513363: The Role of Urinary RhoA, NGF, and BDNF Levels in Overactive Bladder and Vitamin D Deficiency

    Sponsor: Tarik Emre Sener. Phase: NA. Conditions: Overactive Bladder, Vitamin D Deficiency

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT05777993: A Study to Provide Continued Access to Mitapivat for Participants Who Previously Completed an Agios-Sponsored Mitapivat Study

    Sponsor: Agios Pharmaceuticals, Inc.. Phase: PHASE4. Conditions: Pyruvate Kinase Deficiency, Anemia, Hemolytic

    full page →ctgov ↗
    ›SUSPENDEDphase readoutNCT06832293: My MS and My Menstrual Cycle

    Sponsor: University of Alberta. Phase: . Conditions: Multiple Sclerosis, Menstrual Cycle

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06783621: A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVÉDERM® Products, KYBELLA, CoolSculpting Elite and SkinMedica Products

    Sponsor: AbbVie. Phase: PHASE4. Conditions: Facial Contouring

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06044714: Effects of Acupuncture on Perceived Stress and Health in Military Service Members

    Sponsor: United States Naval Medical Center, San Diego. Phase: NA. Conditions: Perceived Stress

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07505004: Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal Seizures

    Sponsor: Praxis Precision Medicines. Phase: PHASE3. Conditions: Focal Epilepsy

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT02636504: Evaluation of Three Pulp Vitality Tests

    Sponsor: Columbia University. Phase: . Conditions: Dental Pulp Diseases, Dental Pulp Vitality Testing

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07459504: SMART Diets for MASLD

    Sponsor: Michigan State University. Phase: PHASE2. Conditions: Metabolic-dysfunction Associated Steatotic Liver Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT01050504: Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

    Sponsor: University of Washington. Phase: . Conditions: Localized Renal Pelvis and Ureter Urothelial Carcinoma, Malignant Solid Neoplasm, Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Neoplasm in the Soft Tissues, Metastatic Renal Pelvis and Ureter Urothelial Carcinoma, Recurrent Bladder Carcinoma, Recurrent Prostate Carcinoma, Recurrent Renal Pelvis and Ureter Urothelial Carcinoma, Stage IV Bladder Cancer AJCC v7, Stage IV Bladder Urothelial Carcinoma AJCC v7, Stage IV Prostate Cancer AJCC v7

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04577404: Safety Extension Study of Oral Edaravone Administered in Subjects With Amyotrophic Lateral Sclerosis (ALS)

    Sponsor: Tanabe Pharma America, Inc.. Phase: PHASE3. Conditions: Amyotrophic Lateral Sclerosis (ALS)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07336147: Dostarlimab, Cisplatin and Etoposide in Combination With Radiotherapy in Sandwich Sequence for Small Cell Neuroendocrine Cervical Carcinoma

    Sponsor: Chang Gung Memorial Hospital. Phase: PHASE2. Conditions: Female

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07397247: Tonic Motor Activation (TOMAC) Therapy in Patients With Restless Legs Syndrome and Dopaminergic Augmentation

    Sponsor: Noctrix Health, Inc.. Phase: NA. Conditions: Restless Legs Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05030038: Oral Aromatase Inhibitors Modify the Gut Microbiome

    Sponsor: Wake Forest University Health Sciences. Phase: . Conditions: Breast Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07357558: A Qualitative Study Investigating the Lived Experiences and Impact of Reproductive Issues in Adults With Primary Ciliary Dyskinesia

    Sponsor: University Hospital Southampton NHS Foundation Trust. Phase: . Conditions: Primary Ciliary Dyskinesia (PCD)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05070858: A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis

    Sponsor: Regeneron Pharmaceuticals. Phase: PHASE3. Conditions: Generalized Myasthenia Gravis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07145658: Multivitamin for Health and Cognition

    Sponsor: Dr Anthony Hobson. Phase: NA. Conditions: Healthy, Cognition, Health

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06666348: Phase 1/2 Study of Mirdametinib + Vinblastine for Newly Diagnosed/Previously Untreated PLGG + Activation of MAPK

    Sponsor: St. Justine's Hospital. Phase: PHASE1. Conditions: Pediatric Low-grade Glioma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06471426: The Effect of Osteopathic Treatment on Craniocervico-Mandibular Dysfunction

    Sponsor: Edward Via Virginia College of Osteopathic Medicine. Phase: NA. Conditions: Headache, Neck Pain

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03328026: Combination Study of SV-BR-1-GM With Retifanlimab

    Sponsor: BriaCell Therapeutics Corporation. Phase: PHASE1. Conditions: Breast Cancer, Breast Neoplasm, Metastatic Breast Cancer, Breast Cancer Metastatic

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07593326: Midwife-Led Antenatal Perineal Massage Education in Primiparous Pregnant Women

    Sponsor: Atlas University. Phase: NA. Conditions: Pregnancy, Fear of Childbirth, Antenatal Education

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03555578: Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg "All-Case Investigation: Spinal and Bulbar Muscular Atrophy (SBMA)"

    Sponsor: Takeda. Phase: . Conditions: Spinal and Bulbar Muscular Atrophy

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05288985: Impact of Loco-regional Analgesia Following Placement of Erector Spinae Plane Catheter in Addition to Systemic Analgesia in Patients With Thoracic Trauma

    Sponsor: Centre Hospitalier Departemental Vendee. Phase: NA. Conditions: Trauma Abdomen

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04250077: We The Village Family Support Study

    Sponsor: We The Village, Inc.. Phase: NA. Conditions: Community Reinforcement And Family Training, Family Health, Substance-Related Disorders

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07444957: Safety and Effectiveness of the Crystalline Sirolimus-Eluting Device in Patients With Coronary Artery Disease

    Sponsor: Fundación Interhospitalaria para la Investigación Cardiovascular FIC. Phase: . Conditions: Coronary Arterial Disease (CAD), NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI), Stable Angina, Unstable Angina, NSTEMI, Drug Coated Balloon, ST-Elevation Myocardial Infarction, Silent Ischemia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06605001: Development, Attention, and Inhibition Study

    Sponsor: University of California, Davis. Phase: NA. Conditions: The Ability to Delay Gratification

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07278375: Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome

    Sponsor: HELP for NOWS Consortium. Phase: . Conditions: Neonatal Opioid Withdrawal Syndrome

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07412275: Microwave Intervention Under Local Anesthesia

    Sponsor: Koelis. Phase: NA. Conditions: Localised Prostate Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07369895: Clinical Study of O&D-001 Injection in the Treatment of Relapsed or Refractory Multiple Myeloma

    Sponsor: O&D BioTech Group CO., Limited. Phase: PHASE1. Conditions: Relapsed or Refractory Multiple Myeloma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04773457: Neutrophil Phenotypic Profiling and Surgical Site Infections in Surgical Patients

    Sponsor: Boston Children's Hospital. Phase: . Conditions: Surgical Site Infection

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06463457: Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED)

    Sponsor: Atish Choudhury, MD. Phase: PHASE2. Conditions: Prostate Cancer, Advanced Prostate Cancer, Hormone Sensitive Prostate Cancer

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT06535477: Fall Risk Assessment With an Innovative Device for Quantifying Gait and Static Balance in Geriatric Consultation

    Sponsor: Gérond'if. Phase: NA. Conditions: Risk of Falling in the Elderly

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07347457: Functional Rehabilitation Effects on Exercise-induced Hypoalgesia in Chronic Low Back Pain

    Sponsor: Clinique de la Mitterie. Phase: NA. Conditions: Low Back Pain

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07495553: Web-Based Filial Therapy In Pediatric Cancer

    Sponsor: serap güleç keskin. Phase: NA. Conditions: Pediatric Cancer, Parental Stress, Parenting Anxiety

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06075745: Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates

    Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: PHASE2. Conditions: Liver Transplant

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07471672: Spot Compression Ultrasound Compared to Traditional Breast Ultrasound

    Sponsor: Duke University. Phase: NA. Conditions: Breast Mass

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06283472: Enhancing Prospective Thinking in Early Recovery (BEAM)

    Sponsor: Indiana University. Phase: NA. Conditions: Alcohol Use Disorder

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT05899595: Effects of a Personalized Physical Training to Reduce Fatigue

    Sponsor: Centre Hospitalier Universitaire de Saint Etienne. Phase: NA. Conditions: Fatigue Syndrome, Chronic

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03513939: A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch™ for Clinical Islet Transplantation

    Sponsor: Sernova Biotherapeutics Inc.. Phase: PHASE1. Conditions: Type 1 Diabetes Mellitus

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05289739: Exercise Training in Childhood Cancer

    Sponsor: Johannes Gutenberg University Mainz. Phase: NA. Conditions: Pediatric Oncology

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06339177: Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study

    Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: . Conditions: Lymphohistiocytosis, Hemophagocytic, Secondary Hemophagocytic Lymphohistiocytosis, Macrophage Activation Syndrome, Hyperinflammatory Syndromes

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07336277: Sleep Quality and the Efficacy of a Multimodal Sleep Pathway in Hospitalized Orthopedic Trauma Patients

    Sponsor: Emory University. Phase: PHASE3. Conditions: Orthopedic Trauma, Sleep Quality

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07238075: ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers

    Sponsor: Adcytherix SAS. Phase: PHASE1. Conditions: Advanced Malignancy, Advanced Solid Cancers, Metastatic Solid Tumors

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06746675: Evaluating the Healthy Families PrEP Program for Women at Risk for HIV

    Sponsor: Yale University. Phase: NA. Conditions: HIV, Pregnancy, Pre-Exposure Prophylaxis of HIV Infection

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06807957: Inspiratory Muscle Training in Amateur CrossFit® Athletes

    Sponsor: Federal University of the Valleys of Jequitinhonha and Mucuri. Phase: NA. Conditions: Healthy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06975657: Well-being Skills for Reentry

    Sponsor: University of Wisconsin, Madison. Phase: NA. Conditions: Formerly Incarcerated Adults

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06050577: The Effect of Oral Semaglutide on Bone Turnover in Patients With T2D: a Randomized Placebo-controlled Clinical Trial

    Sponsor: Odense University Hospital. Phase: PHASE2. Conditions: Type 2 Diabetes, Osteopenia

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT01980277: Phase Ib/II Study of LY2780301 in Combination With Weekly PACLITAXEL in HER2-metastatic Breast Cancer

    Sponsor: Institut Paoli-Calmettes. Phase: PHASE1. Conditions: Breast Cancer

    full page →ctgov ↗
    ← prev
    page 39 of 96
    next →